To investigate whether the expression of a dominant negative (DN) farnesyl-and geranygeranyl-transferase I (FTase=GGTase I) a-subunit in 3T3-L1 pre-adipocytes can inhibit insulin's ability to induce differentiation. DESIGN: 3T3-L1 pre-adipocytes were stably transfected with vector alone or vector expressing a mutated DN FTase=GGTase I a-subunit (S60A)(S62A) and incubated in serum-free medium in the absence and presence of insulin. MEASUREMENTS: Various assays were performed to determine the effect of DN FTase=GGTase I a-subunit expression in 3T3-L1 pre-adipocyte on insulin-induced DNA synthesis, cell count, phosphorylation of the FTase=GGTase I a-subunit, FTase and GGTase I activity, amounts of prenylated p21Ras and RhoA, phosphorylation of MAP kinase and Akt, and differentiation to mature fat cells. RESULTS: Expression of DN FTase=GGTase I a-subunit inhibited insulin's ability to increase DNA synthesis, cell count, FTase and GGTase I activity, amounts of prenylated p21Ras and RhoA, and magnitude of phosphorylation of MAP kinase. Expression of DN FTase=GGTase I a-subunit in 3T3-L1 pre-adipocytes was without effect on insulin-induced Akt phosphorylation. CONCLUSION: Expression of DN FTase=GGTase I a-subunit inhibits insulin-induced differentiation of 3T3-L1 pre-adipocytes to mature adipocytes, and thus could indicate potential therapeutic avenues to assuage the deleterious effects of obesity and type 2 diabetes.
Introduction
Insulin is a critical regulator of many aspects of adipocyte physiology. 1, 2 In addition, insulin appears to be a major factor in differentiation of pre-adipocytes into mature adipocytes. 3 Adipocyte differentiation begins with clonal expansion (DNA synthesis and increased cell count), followed by increases in the expression of transcription factors such as CCAAT= enhancer-binding proteins (C=EBP) and differentiation marker proteins such as the signal transducers and activators (STAT), peroxisome proliferator-activated receptor (PPAR), and signal pathway proteins such as p110b, the catalytic subunit of phosphatidylinositol 3-kinase (PI 3-kinase). 3, 4 The mechanism of insulin's effect on adipocyte differentiation is incompletely understood. In particular, little is known about the interactions of the insulin signaling machinery with the differentiation cascade, which involves the expression of several members of the C=EBP family, PPARg, leptin, GLUT-4 and Fas. 4 We have recently shown that in 3T3-L1 pre-adipocytes insulin stimulates the phosphorylation and activation of the cyclic-AMP response element bindingprotein (CREB), which may possibly link the insulinsignaling pathway with the activation of the differentiation cascade.
5 Furthermore, we demonstrated that insulinstimulated phosphorylation of CREB and subsequent preadipocyte differentiation was blocked by the inhibition of prenylation of p21Ras and RhoA, 5 suggesting that the availability of prenylated p21Ras and RhoA is necessary for insulin-induced differentiation of pre-adipocyte into mature fat cells.
Prenylation of p21Ras and RhoA is mediated by the enzymes, farnesyltransferase (FTase) and geranylgeranyltransferase I (GGTase I), respectively. 6, 7 FTase and GGTase I are heterodimers and share the same a-subunit, 8 whereas the b-subunit confers substrate specificity. 7, 9 We have demonstrated that insulin promotes the phosphorylation and activation of FTase and GGTase I and thereby increases the amounts of prenylated p21Ras and RhoA. 10 -12 Recently, we designed a mutated FTase=GGTase I a-subunit (S60A)(S62A) that acts as a dominant negative (DN) form of both enzymes 13 and inhibits insulin-stimulated phosphorylation and activation of FTase and GGTase I, as well as subsequent prenylation of p21Ras and RhoA, and synthesis of DNA in vascular smooth muscle cells 13 and MCF-7 breast cancer cells. Because the availability of prenylated p21Ras and RhoA appears to be critical for adipocyte differentiation, we explored the effect of this dominant negative FTase mutant, DN FTase=GGTase I a-subunit, on the ability of insulin to stimulate differentiation of 3T3-L1 pre-adipocytes. 
Materials and methods

Materials
Transfection of pCMV-Tag2A=DN
FTase=GGTase I a-subunit into 3T3-L1 cells Cells were grown to 50% confluence in fibroblast growth medium (FGM; DMEM low glucose, 10% fetal bovine serum, 50 mg=ml gentamicin, 1 mM glutamine, 1.25 mg=ml fungizone). The 3T3-L1 cells were transfected with either vector (pCMVTag 2A) alone (Control) or with the DN FTase=GGTase I a-subunit expression plasmid (pCMV-Tag 2A=DN FTase= GGTase I a-subunit [(S60A)(S62A)]), 13 using Lipofectamine and Plus Reagent as per the manufacturer's protocol. Cells were incubated in FGM for 24 h to allow expression of the DN FTase=GGTase I a-subunit. Stable lines of transfected cells were maintained using G418 (Geneticin) selection.
Insulin-stimulated phosphorylation of FTase a-subunit Transfected cells were incubated for 6 h in serum-and phosphate-free medium and pre-incubated with 250 mCi [ 32 P]orthophosphate for 24 h. Cells were incubated for 60 min in the absence or presence of insulin (10 nM), and then lysed with Buffer I previously described. 10 FTase was immunoprecipitated from lysates using anti-FTase b-subunit antibodies. FTase a-and b-subunits were resolved by SDS -PAGE. The magnitude of phosphorylated FTase a-subunit was visualized by autoradiography, whereas the amount of FTase a-subunit protein was determined by Western blotting. Quantities of each were measured by densitometry.
Insulin-stimulated phosphorylation of GGTase I a-subunit Transfected cells were incubated for 6 h in serum-and phosphate-free medium and pre-incubated with 250 mCi [ 32 P]orthophosphate for 24 h. Cells were incubated for 60 min in the absence or presence of insulin (10 nM), and then lysed with buffer I. FTase was immunoprecipitated from lysates using anti-FTase b-subunit antibodies. GGTase a-subunit was immunoprecipitated from cleared lysates using anti-GGTase a-subunit antibodies and analyzed by SDS -PAGE. The magnitude of phosphorylated GGTase a-subunit was visualized by autoradiography and the amount of protein was determined by Western blotting. Quantities of each were measured by densitometry.
Insulin-stimulated FTase and GGTase I activity Transfected cells were incubated in serum-free medium in the presence or absence of insulin (10 nM) for 60 min. The in vitro filtration assay was performed as previously described. 10, 14 The amount of labeled protein was quantified by scintillation spectrometry.
Separation of prenylated and unprenylated p21Ras and RhoA Transfected cells were incubated in serum-free medium in the absence or presence of insulin (10 nM) for 60 min. Lysates were normalized for protein and mixed with an equal volume of 4% Triton X-114, and incubated at 37 C for 3 min. The aqueous and detergent phases were allowed to separate at room temperature as previously described. 10, 14 Prenylated and unprenylated p21Ras and RhoA were resolved by SDS -PAGE, determined by Western blotting, and quantified by densitometry.
Insulin-stimulated DNA synthesis assay: BrdU incorporation Transfected cells were incubated in serum-free medium with or without insulin (10 nM) for 24 h. Cells were incubated in the presence of 5-bromo-2 0 -deoxyuridine (BrdU) for 6 h. BrdU incorporation was determined by Cell Proliferation ELISA (Boehringer Mannheim), and quantified by colorimetry. Insulin-stimulated phosphorylation of Akt and MAP kinase proteins Transfected cells were incubated in serum-free medium with or without insulin (10 nM) for 10 min. Akt and MAP kinase were immunoprecipitated from lysates using the appropriate antibodies. Akt and MAP kinase proteins were analyzed by SDS -PAGE and the magnitude of insulin-stimulated phosphorylation of each protein was determined by Western Blotting using the appropriate anti-phosphoprotein antibodies. Protein content was determined by stripping the membranes followed by Western blotting using the appropriate anti-protein antibodies.
Insulin-stimulated activation of PI 3-kinase Transfected cells were incubated in serum-free medium with or without insulin (10 nM) for 10 min. IRS-1 was immunoprecipitated and washed with isotonic PBS containing 1% Nonidet P-40, then washed once with buffer 1 (0.5 M LiCl, 100 mM Tris -HCl, pH 7.6) and twice with buffer 2 (10 mM Tris -HCl, 100 mM NaCl, 1 mM EDTA, pH 7.4) and lyophilized. Pellets were re-suspended in 50 ml of buffer 2, 10 ml of 100 mM MgCl2 and 10 ml of phosphoinositol mixture (0.5 mg=l of phosphoinositol in 10 mM Tris-HCl=1 mM EGTA). Reactions were initiated by adding 10 ml of ATP mixture (100 mM MgCl 2 , 10 nM Tris -HCl (pH 7.2), 0.55 mM ATP, 1 mCi=ml [ 32 P]-ATP) and incubated for 10 min at room temperature. Reactions were stopped using 20 ml of 8 N HCl. A solution of 160 ml of CHCl 3 :MeOH (1:1, v=v) was added, centrifuged and the organic layer wastransferred to a new tube and contents lyophilized. Contents were resuspended in 10 ml of methanol. Samples were loaded onto a silica-60 TLC plate coated with 1% potassium oxalate. Samples were resolved using CHCl 3 :MeOH:H 2 O,NH 4 OH (60:47:11:3:2, v=v). TLC plates were air-dried and phosphorylated phosphoinositol was visualized using autoradiography.
Insulin-stimulated pre-adipocyte differentiation Transfected cells were incubated in FGM until 100% confluent. FGM was replaced with differentiation mix (DMEM high glucose, 10% fetal bovine serum, 50 mg=ml gentamicin, 1 mM glutamine, 1.25 mg=ml fungizone, 110 mg=ml isobutylmethylxanthene, 24.5 mM dexamethasone, and 5 mg=ml insulin) for 48 h. The differentiation mix was replaced with adipocyte growth medium (AGM; DMEM high glucose, 10% fetal bovine serum, 50 mg=ml gentamicin, 1 mM glutamine, 1.25 mg=ml fungizone) plus 1 ng=ml insulin for 48 h, and then replaced every 2 days with AGM alone.
Statistical analysis
All statistics were analyzed by the Student's t-test, with a P-value of < 0.05 considered significant. Results are expressed as the mean AE s.e.m. of three independent experiments, or otherwise noted.
Results
We initially assessed DNA synthesis and cell counts in 3T3-L1 pre-adipocytes as direct measurements of insulin-stimulated pre-adipocyte clonal expansion in control cells and DN FTase a-subunit inhibits adipocyte differentiation CS Solomon et al cells expressing the dominant negative mutant FTase= GGTase I a-subunit (S60A)(S62A) (DN FTase=GGTase I a-subunit). Cells were transfected with either vector alone (controls) or the expression vector (CMV-Tag2A=FTase a-subunit (S60A)(S62A)). In control cells, insulin (10 nM) stimulated DNA synthesis 41 AE 4.7% above that found in nontreated controls ( Figure 1A) . However, cells transfected with the DN FTase=GGTase I a-subunit and challenged with insulin showed no increases in DNA synthesis as compared to nontreated cells ( Figure 1A) . Additionally, insulin significantly (P < 0.05) stimulated increases in cell counts 106 AE 13.9% above controls, but was without effect in cells expressing the DN FTase=GGTase I a-subunit ( Figure 1B) . We then examined the effect of DN FTase=GGTase I a-subunit on the ability of insulin to stimulate the prenyltransferases FTase and GGTase I and to augment the amounts of prenylated p21Ras and RhoA proteins. Insulin stimulated the phosphorylation of the FTase=GGTase I a-subunit in controls, but not in cells transfected with the DN FTase= GGTase I a-subunit ( Figure 2 ). As expected, insulin was able to stimulate both FTase and GGTase I activity 395 AE 70.4% and 290 AE 78.4%, respectively, above nontreated controls ( Figure 3 ). In comparison, cells expressing the DN FTase= GGTase I a-subunit, exhibited both FTase and GGTase I basal activities only slightly below those of controls (Figure 3) . However, insulin failed to increase FTase and GGTase I activities above basal levels in these cells (Figure 3) .
Because insulin-stimulated increases in FTase and GGTase I activities are reflected in subsequent increases in the amounts of prenylated p21Ras and RhoA, 10,12,14 -17 we examined the effect of DN FTase=GGTase I a-subunit on insulin-stimulated prenylation of p21Ras and RhoA in 3T3-L1 pre-adipocytes. Serum-starved control cells contained 40 -42% prenylated p21Ras ( Figure 4A ) and RhoA ( Figure 4B ), whereas insulinstimulated control cells exhibited an increase in the amounts of farnesylated p21Ras to 61% ( Figure 4A ) and geranylgeranylated RhoA to 54% ( Figure 4B ) of total cellular p21Ras and 
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RhoA, respectively. In contrast, the amounts of prenylated p21Ras and RhoA in cells expressing the DN FTase=GGTase I a-subunit were not increased in the presence of insulin ( Figure 4A and B).
The inability of insulin to augment the amounts of prenylated p21Ras and RhoA in the presence of the DN FTase= GGTase I a-subunit was accompanied by a diminished insulin effect on the magnitude of phosphorylation of the mitogen activated protein kinase, ERK (extracellular signalregulated kinase), a kinase downstream of p21Ras. 18 -20 Control cells treated with insulin showed appropriate increases in the magnitude of the phosphorylated forms of ERK ( Figure 5A ). However, cells expressing the DN FTase= GGTase I a-subunit showed diminished insulin-stimulated phosphorylation ERK ( Figure 5A ). In contrast, insulin was able to promote the phosphorylation of Akt in control cells and those expressing the DN FTase=GGTase I a-subunit ( Figure 5B ), and expression of DN FTase=GGTase I a-subunit did not inhibit insulin-promoted phosphorylation of PI 3-kinase ( Figure 5C ).
Because insulin-induced differentiation in 3T3-L1 preadipocytes has been shown to be blocked by inhibitors of the prenyltransferases, 5 we examined the effect of insulinstimulated differentiation of 3T3-L1 pre-adipocytes expressing the DN FTase=GGTase I a-subunit. Pre-adipocytes transfected with vector alone (controls) differentiated normally in the presence of insulin ( Figure 6 , upper panel). In contrast, pre-adipocytes that expressed the DN FTase= GGTase I a-subunit were refractory to insulin ( Figure 6 , lower panel) and did not differentiate during the 10 day experimental course. 
Discussion
The salient feature of this report is the demonstration that insulin-induced adipocyte differentiation is completely prevented when 3T3-L1 pre-adipocytes express a dominant negative mutant of the a-subunit of FTase and GGTase I. Adipocyte differentiation has recently become an important and an intense topic of research. Aberrations in adipose tissue development are seen to correlate with Type 2 diabetes, 21 obesity, and some types of cancers and immune dysfunctions. 22 The process of differentiation of pre-adipocyte to adipocyte has been studied in cell lines because in vitro models faithfully recapitulate fat cell development in vivo.
23
Adipocyte differentiation signaling cascades have been partially characterized, but still remain elusive to exact interpretations of biochemical pathways and interactions. Many reviews have summarized the current understanding of the mechanisms involved with adipocyte differentiation. 1, 3, 4, 24, 25 These reviews stress that during adipocyte differentiation, and regardless of the nature of the inducing event, a series of transcription factors (ie C=EBPbd and a, and PPARg) are induced in a specific sequence. 1, 3, 4, 24, 25 Although in in vitro studies, dexamethasone (DEX), isobutylmethylxanthine (IBMX) and insulin are used to induce adipocyte differentiation, the most potent of these three is insulin. Insulin's role appears to be important for two reasons: (1) its ability to induce adipocyte differentiation; and (2) its influence in vivo in the state of hyperinsulinemia and the development of obesity. Although in physiological concentrations, insulin induces lipogenesis and adipocyte differentiation, 26 the mechanism of its action on adipogenesis is still not well understood.
It is still unclear which or how many insulin intracellular signal pathway(s) are used to stimulate the differentiation cascades and to induce adipocyte differentiation. However, insulin signaling pathways dedicated to induce the intrinsic cascade of adipocyte differentiation is a hotly debated topic.
In reference to insulin signaling, the presence of the insulin receptor is essential for adipocyte differentiation. 27, 28 Both the phosphatidylinositol 3-kinase (PI 3-kinase) and mitogenactivated protein (MAP) kinase pathways appear to be necessary for adipocyte differentiation.
5, 29 The inhibition of PI 3-kinase by wortmannin and the decrease in cholesterol intermediates such as farnesyl and geranylgeranyl by simvastatin have been shown to block insulin-induced differentiation of 3T3-L1 pre-adipocytes. 29, 30 Whereas a number of other growth factors stimulate the activity of PI 3-kinase and its downstream effectors without effect on adipocyte differentiation, insulin most likely stimulates the activities of other signaling pathway branches in addition to those of PI 3-kinase and MAP kinase to induce adipogenesis.
Although recent experiments have demonstrated a requirement for the activation of the insulin receptor, PI 3-kinase and MAP kinase during adipogenesis, 27 -29 the exact mechanism connecting insulin signaling with the intrinsic mechanisms of adipocyte differentiation remains enigmatic. In a recent study, we demonstrated that at least one mechanism whereby insulin triggers the intrinsic cascade of adipocyte differentiation is its ability to stimulate prenylation. 5 Inhibition of prenylation completely blocked insulin-induced adipocyte differentiation and prevented the induction of C=EBPb and C=EBPa. Additionally, inhibition of the protein prenyltransferase, farnesyltransferase (FTase), also blocked insulin-stimulated activation of MAP kinase and cyclic-AMP response element binding protein (CREB).
Reusch et al 31 have shown that insulin-stimulated activation and phosphorylation of CREB is necessary and sufficient to induce adipogenesis in 3T3-L1 pre-adipocytes. Additionally, expression of a constitutively active CREB species (VP16-CREB) alone was sufficient to induce adipogenesis as determined by the expression of the adipocyte marker genes, PPARg and FAS, triacylglycerol storage and cell morphology. In contrast, the expression of a dominant negative mutant of CREB (KCREB) inhibited insulin-induced adipocyte differentiation. Because insulin promotes the phosphorylation of MAP kinase and CREB, 18, 32 and because the effect of insulin on these two proteins is blocked by the inhibition of the prenyltransferase FTase, we suggest that the connection between the intrinsic adipocyte differentiation cascade and the insulin-signaling cascade occurs by way of the insulinstimulated and MAP kinase-mediated phosphorylation of CREB, and is regulated by the activation of FTase and its farnesylation of p21Ras.
Insulin-stimulated activation of FTase is reflected in increased magnitude of phosphorylation of the a-subunit of FTase 10, 20 with subsequent increases in the amounts of farnesylated p21Ras anchored at the membrane and available for activation by other growth factors. 15, 20, 33 Although insulin promotes only moderate increases in the amounts of insulin-stimulated farnesylated p21Ras, insulin-stimulated activation of FTase and p21Ras is greatly enhanced, thereby effecting significant increases in the magnitude of phosphorylation of MAP kinase and CREB, with subsequent increases 5 Taken together, these data suggest (1) that the insulin-induced activation of CREB is the connection between the two insulin-signaling pathways of Ras-MAP kinase and the intrinsic adipocyte differentiation cascade, and (2) that insulin-stimulated prenylation plays an important role in adipocyte differentiation.
Insulin stimulates two mitotic cell cycles prior to the induction of differentiation and the expression of adipocyte differentiation-specific genes. 34 Insulin effects on adipocyte proliferation and differentiation are mediated by the Ras-MAP kinase pathway. 19 We have recently shown that the activity of the Ras-MAP kinase pathway in 3T3-L1 preadipocytes is dependent on the amounts of GTP-loaded and farnesylated p21Ras, 19 and that increases in the amounts of farnesylated p21Ras are correlated with increases in the activity of FTase. 10 FTase activity is dependent on the phosphorylation state of its regulatory subunit, the a-subunit, and promotion of phosphorylation of the FTase a-subunit is specific to the actions of insulin. 33 We have also demonstrated that the activity of the Ras-MAP kinase pathway is associated with the activity of FTase in a positive feedback relationship. 20 In essence, then, increases in FTase activity are reflected in both increased amounts of prenylated p21Ras and increased insulin signaling via the Ras-MAP kinase pathway.
Recently, we designed a mutated FTase=GGTase I a-subunit (FTase=GGTase I a-subunit (S60A)(S62A)) that exhibits the characteristics of a dominant negative (DN) FTase=GGTase I protein when expressed in vascular smooth muscle cells 13 and MCF-7 breast cancer cells (Solomon and Goalstone, unpublished) . To continue this investigation, we were interested in examining the effects of DN FTase= GGTase I a-subunit on insulin-induced differentiation when expressed in 3T3-L1 pre-adipocytes. Here we show for the first time that the expression of DN FTase= GGTase I a-subunit in 3T3-L1 pre-adipocytes inhibits insulin-stimulated pre-adipocyte DNA synthesis, cell count, and differentiation. In contrast, and as expected, pre-adipocytes transfected with the vector alone and in the presence of insulin showed increased DNA synthesis, cell count and differentiation.
In addition to the inhibitory effect of DN FTase=GGTase I a-subunit on insulin-induced differentiation, we show here for the first time a mechanism by which the expression of DN FTase=GGTase I a-subunit inhibits insulin-induced adipocyte differentiation. First, expression of the DN FTase= GGTase I a-subunit in 3T3-L1 pre-adipocytes blocked insulinstimulated phosphorylation of FTase and GGTase I proteins. Second, decreased FTase and GGTase I phosphorylation was accompanied by decreased FTase and GGTase activity. In concert with the latter, insulin was unable to increase the amounts of prenylated p21Ras and RhoA proteins in 3T3-L1 pre-adipocytes expressing the DN FTase=GGTase I a-subunit as compared with insulin-stimulated controls. Finally, expression of the DN FTase=GGTase I a-subunit in 3T3-L1 pre-adipocytes blocked insulin-promoted phosphorylation of ERK, but was without effect on insulin-stimulated Akt and PI 3-kinase phosphorylation, thus indicating that expression of the DN FTase=GGTase I a-subunit blocks insulin signaling via the mitogenic pathway but not through the metabolic pathway. Taken together, these results are in agreement with previous studies that indicate that insulininduced differentiation of 3T3-L1 pre-adipocytes is mediated by the Ras-MAP kinase pathway.
5, 18 Additionally, these data suggest a possible mechanism by which FTase and GGTase I activity, along with prenylation of p21Ras and RhoA, have an effect on insulin-promoted differentiation of 3T3-L1 adipocytes.
Prenylation of p21Ras and RhoA is a post-translational modification event mediated by FTase and GGTase I, respectively. 6, 7 However, it has been shown that inhibition of FTase can result in geranylgeranylation of some Ras proteins. 35 Thus, using the DN FTase=GGTase I a-subunit to block both FTase and GGTase I protein activity, would prevent prenylation of Ras proteins via an alternate path. Additionally, because FTase and GGTase I share the same a-subunit, intracellular expression of a dominant negative FTase= GGTase I a-subunit would then moderate or ablate the function of both of these two prenyltransferases thereby effecting decreases in the amounts of prenylated p21Ras and RhoA. Prenylation of p21Ras and RhoA promotes the anchorage of these GTPases to specific membranes in the cell and allows these proteins to mediate signals from extracellular signaling. 5, 11, 12, 15, 36 Adipocyte differentiation is promoted by extracellular signals and, because it appears to be mediated via the Ras-MAP kinase pathway, the activity of FTase and GGTase I and the amounts of prenylated p21Ras and Rho are then germane to this process. Accordingly, even though forced expression of an inhibitor (eg through viral transmission) could be fraught with problems, such as the absence of fat cell growth=differentiation can be metabolically quite deleterious, the expression of DN FTase=GGTase I a-subunit, which inhibits insulininduced differentiation of 3T3-L1 pre-adipocytes to mature adipocytes, could indicate potential therapeutic avenues to assuage the deleterious effects of obesity and type 2 diabetes. Goalstone ML, Draznin B. Insulin-induced adipocyte differentia
